Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by skier59on Dec 23, 2021 7:10pm
172 Views
Post# 34259701

RE:RE:Has CV19 kept the burn so loe?

RE:RE:Has CV19 kept the burn so loe?enriquesuave, always enjoy reading your posts !

TractorTom, always wondered how much they pay You, for these posts ?

Yes, you were right on that last disgusting raise. Your Boss, succeeded and got Us cheap.

Doesn't mean your Gang, will get us the next time.

Seems we have a Safe House, and fantastic results so far !.....more to come ?.....I'm feeling good, providing the procedure is properly monitored. This is not a pill, far better and efficient.

Forget the Vaccine, that will cheapen Us.... Why do you ask, because you will have to sell it cheap, which then cheapen the value of our primary goal, cancer treatment. Let the Pharma's fight it out for Virus treatments. We know ours works, but so does Human Immunity to viruses. As viruses tend to change, so do we, and their goal of inflicting the majority, takes other paths, which weaken their strength, as happened throughout history. It is happening now with Omicron.

My best friends family of 4, having 2 teenage boys, 3 have Omicron since last weekend. The youngest at 14 does not yet have it. They were all double-vaccinated. 

Like I told him, how many times in the past have we tested Humans for viruses? Like NEVER.
But now we are pumping out tests like human kind has never experienced. So, we will find it, like never before.

How many times have we had 25% of the office sick at the same time, or close to during a 3 month period......Almost ALWAYS each year.

The vaccinations have certainly saved a ton of people, and helped control the spread. Vaccinations are very important, and I'm getting my Booster next week.

You all should too.

Cheers, hopefully we will have something, that will have Us all, excited the end of February 2022.

On that note, I'm wishing all Theralase Shareholders, a very Happy and Prosperous New Year.




Be it a bad 




enriquesuave wrote:

When data will hopefully soon conclusively place TLD-1433 as the (or one of the) top contenders as a new Gold Standard for BCG UnResponsive NMIBC, then SP may surely rise to levels never before reached.  At that time point, excercise of warrants and/or a raise would be appropriate.  We all know it's coming soon enough and the company has more than enough cash to get us there.  So long as data is consistently good in the next batch.  All IMHO 

 

SouthernTierTom wrote: I was estimating that there was about 3.5M CAD in the kitty...

Seems a bit of a catch 22, if trial activity ramps up s we hope....so will burn.

We had about 1.6M or so in the kitty tha last time we "raised", but we are now deep into the phase 2 experience that includes operations here in the US.

I would not at all be unhappy with a "raise"...but at what price?

Thoughts,

Tuckey?...Macer? ; - )
 

 

 



<< Previous
Bullboard Posts
Next >>